COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

NCT06880042 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Vitiligo - Macular Depigmentation
Tacrolimus

Interventions

DRUG: Tacrolimus
DRUG: Calcipotriol

Sponsor

Dr ayesha wahid